Request Deal Involvement

Calliditas Therapeutics completed the acquisition of a 62.7% stake in Genkyotex for €88m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Stifel

financial advisors

Stifel

NewCap

pr advisors

NewCap

McDermott Will & Emery

legal advisors

McDermott Will & Emery

Latham & Watkins

legal advisors

Latham & Watkins

Bryan Garnier

financial advisors

Bryan Garnier

Vinge

legal advisors

Vinge

Eubelius

legal advisors

Eubelius

Mannheimer Swartling

legal advisors

Mannheimer Swartling

or

Principals

GENKYOTEX

target

GENKYOTEX

CALLIDITAS THERAPEUTICS

bidder

CALLIDITAS THERAPEUTICS

WELLINGTON PARTNERS GMBH

vendor

WELLINGTON PARTNERS GMBH

ANDERA PARTNERS

vendor

ANDERA PARTNERS

NEOMED MANAGEMENT

vendor

NEOMED MANAGEMENT

VESALIUS BIOCAPITAL PARTNERS SARL

vendor

VESALIUS BIOCAPITAL PARTNERS SARL

ECLOSION2

vendor

ECLOSION2

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite